Cargando…
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation
Chemoradiotherapy can induce immunogenic cell death, triggering danger signals such as high-mobility group box 1 protein, and resulting in T-cell immunity. This concept can potentially be harnessed for clinical therapy to enhance tumor-specific immunity. There is however limited information to trans...
Autores principales: | Kono, K, Mimura, K, Kiessling, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702303/ https://www.ncbi.nlm.nih.gov/pubmed/23788045 http://dx.doi.org/10.1038/cddis.2013.207 |
Ejemplares similares
-
Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
por: Kono, Koji, et al.
Publicado: (2013) -
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
por: Garg, Abhishek D., et al.
Publicado: (2015) -
Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma
por: Aoto, Keita, et al.
Publicado: (2018) -
Immunogenic Cell Death Induced by Chemoradiotherapy of Novel pH-Sensitive Cargo-Loaded Polymersomes in Glioblastoma
por: He, Chen, et al.
Publicado: (2021) -
Immunogenic effects of chemotherapy-induced tumor cell death
por: Wang, Yi-Jun, et al.
Publicado: (2018)